U.S. Biotech Stock News

Tech stocks, including DoubleVerify Holdings (DV), came under pressure after an oil shock and a renewed U.S. naval blockade on Iran raised concerns about prolonged higher interest rates and tighter funding conditions. See our latest analysis for DoubleVerify Holdings. The latest pullback in DoubleVerify Holdings reflects the broader risk-off mood in tech, with the stock down 3.22% on a 1 day share price return basis and 2.14% over 7 days. Its 30 day share price return of 10.55% and year to...

Universal Insurance Holdings has delivered a very strong 265.7% total return over the past 5 years, yet its current valuation checks and intrinsic value estimate both indicate the stock still trades at a discount to what the business may be worth. With the share price at US$38.91, the Excess Returns model and earnings multiples are broadly aligned in suggesting the market could be pricing Universal Insurance Holdings below its intrinsic value. Over 5 years, the stock is up 265.7%, which puts...

Ames National (ATLO) has posted Q2 2026 results with total revenue of US$18.9 million and net income of US$5.9 million, translating to basic EPS of US$0.67 and a trailing twelve month EPS of US$2.59. Over recent quarters the company has seen revenue move from US$16.0 million in Q2 2025 to US$18.9 million in Q2 2026, while quarterly EPS shifted from US$0.51 to US$0.67 and trailing net income reached US$23.0 million. This gives investors a clearer picture of earnings momentum backed by a...

Fifth Third Bancorp (FITB) opened Q2 2026 with total revenue of US$3.1 billion and basic EPS of US$0.84, putting fresh numbers on the table for investors tracking its profit engine. The company reported quarterly revenue of US$2.1 billion in Q2 2025 and US$3.1 billion in Q2 2026, while basic EPS over the same quarters moved from US$0.88 to US$0.84, setting the scene for a set of results where profitability and margins are firmly in focus. See our full analysis for Fifth Third Bancorp. With...

Lindsay Corporation recently announced that Senior Vice President and Chief Financial Officer Sam Hinrichsen will resign effective August 31, 2026, for personal reasons, while continuing to provide transition services through year-end under a written agreement. The company also increased its regular quarterly dividend to US$0.38 per share, a move that can underscore management’s confidence in ongoing cash generation and capital-return priorities. Next, we’ll assess how the dividend increase,...

Establishment Labs Holdings has delivered a strong 122.7% return over the past year, yet its valuation checks lean expensive, with the stock flagged as overvalued on market multiples and scoring poorly on broader value tests. Over the last 1 year, Establishment Labs Holdings has returned 122.7%, which puts extra attention on whether the current share price already reflects much of the good news. Expectations for continued business expansion and cash generation can support a premium, but any...

With inflation trends, interest-rate expectations, and energy prices all pulling markets in different directions, many investors are looking for stocks where analysts still see clear earnings growth potential alongside balance sheets that appear reasonably sound. That is exactly what the Healthy high growth potential screener targets, focusing on companies where analysts expect solid earnings expansion over the next 3 years while also passing basic financial health checks. In this article,...

Regency Centers stock has delivered a 55.4% return over the past 5 years, and both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares trading below what those models suggest, yet the broader valuation checks send a more mixed signal. With the share price recently closing at US$82.68, the question is how much room is left before that apparent discount is fully reflected. Regency Centers has returned 55.4% over 5 years, which puts...

Rising geopolitical tensions, questions around US policy, and heavy use of monetary and fiscal stimulus are pushing many investors toward large cap US stocks that look reasonably priced and pay dividends. Instead of chasing the AI boom or trying to guess the next hot trend, this article focuses on value oriented blue chips that may hold up when sentiment swings. Using a US Large Cap Value Stocks screener built around the latest macro shocks, the sections that follow highlight 3 stocks that...

First Commonwealth Financial stock has quietly put up an 88.2% total return over the past five years. Today the Excess Returns intrinsic value estimate still points to meaningful upside relative to the current US$21.12 share price, even as market based valuation checks suggest the stock is only roughly in line with peers. Over five years, a total return of 88.2% puts First Commonwealth Financial in the category of a steadily compounding bank stock, rather than a short term momentum...

Gorilla Technology Group (GRRR) has drawn fresh attention after announcing a private placement of $125 million in 7.50% senior unsecured convertible notes, aimed at funding its NeutraDC Batam data center project in Indonesia. See our latest analysis for Gorilla Technology Group. The NeutraDC Batam financing news lands at a tense moment for Gorilla Technology Group, with the stock’s 7 day share price return down 32.92% and its 1 year total shareholder return declining 36.76%, even as a 4.88% 1...

Arcosa (ACA) has drawn investor attention after recent share price moves, with the stock last closing at $145.01. That price, along with its recent returns, is prompting closer review of the company’s infrastructure-focused business mix. See our latest analysis for Arcosa. The recent move to $145.01 comes after a 30 day share price return of 8.92% and a 90 day share price return of 26.67%, while the 1 year total shareholder return of 61.41% points to stronger momentum over a longer...

Tariff policy is back in the spotlight, and global freight and logistics stocks are feeling the pressure. With importers delaying shipments, ocean freight rates under strain, and trading partners racing to adjust supply chains, the gap between potential winners and losers can widen quickly. For investors watching these moves, the key question is which stocks might struggle most if uncertainty around U.S. tariffs lingers. This article examines three stocks exposed to the latest tariff driven...

Geopolitics, energy prices, inflation trends, and shifting bond yields are all back in focus, and many investors are looking for sectors that are closely linked to these forces. The Aerospace and Defense screener targets companies that manufacture or provide services to these industries, an area many investors watch when geopolitical risk and government spending priorities are front of mind. With inflation data softening in some regions, rate expectations adjusting, and safe haven demand...

Bank OZK stock has delivered a 52.4% return over the past five years, and with a recent share price of US$52.01 the valuation checks now point to a company that still screens as inexpensive rather than stretched. Over five years, a 52.4% total return suggests Bank OZK has already rewarded patient shareholders while still inviting questions about how much value is left on the table. Profitability supported by disciplined underwriting and capital returns such as the recently announced buyback...

Universal Display (NasdaqGS:OLED) has been identified as a highly attractive takeover target. The interest centers on its strong balance sheet, significant net cash position, and extensive patent portfolio. The company’s shareholder-friendly structure, including the absence of dual-class shares, is seen as supportive of a potential deal. Universal Display, known for its organic light emitting diode materials and technologies, sits at the intersection of display manufacturing, specialty...

Gas near $4 a gallon, record household debt of $18.8b and credit card delinquencies at a 16 year high are putting the squeeze on both consumers and the companies that rely on them. At the same time, some energy related stocks may see earnings power shift as supply disruptions ripple through the system. This article walks through three stocks exposed to the Iran conflict and inflation shock: one that could benefit from higher energy prices and two where rising defaults and weaker discretionary...

STAAR Surgical stock has staged a strong rebound over the past year, yet its valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to some upside while traditional market multiples suggest the shares are not cheap. Over the past 5 years, STAAR Surgical has delivered a return of about 80% in decline, which puts the recent share price recovery in a very different light for long term holders. Recent sales momentum in Asia Pacific and recovering...

LXP Industrial Trust (LXP), a US based REIT focused on Class A warehouse and distribution assets, has drawn fresh attention after recent share price moves and its latest reported financial metrics. See our latest analysis for LXP Industrial Trust. At a share price of $58.51, LXP Industrial Trust has seen momentum build recently, with a 1 month share price return of 11.64% and an 18.01% year to date share price return contributing to a 50.16% 1 year total shareholder return. If LXP has put...

Packaging Corporation of America stock has more than doubled over the past five years, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a large discount while market multiples paint a richer picture. Shareholders have seen a 102.1% return over 5 years, which puts the recent share price in focus for anyone thinking about what is already priced in. On the positive side, steady cash generation from packaging demand can support the DCF...

Insmed reported positive 12 month open label extension data for TPIP in pulmonary arterial hypertension. The study showed sustained improvements in six minute walk distance and NT proBNP, with no new safety signals reported. These results support Insmed’s plan to advance TPIP into a Phase 3 randomized, controlled trial. For investors tracking Insmed, ticker NasdaqGS:INSM, the TPIP update adds a fresh data point to a stock that has moved sharply over multi year periods, with a very large 3...

With SpaceX stock under pressure, higher short interest and bond market stress are pushing some investors to reassess where they want to take risk in the space and aerospace theme. That is where a value-focused screener can help. By filtering for companies with market caps above $300 million, lower price multiples, moderate balance sheet risk and dividend potential, it aims to surface stocks that may be better aligned with a more cautious mood. This article walks through 3 stocks exposed to...

Flex stock has delivered a very large 5 year gain, yet the current valuation checks suggest the shares still trade at a discount, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to undervaluation despite the recent pullback. Over the last 5 years, Flex has returned about 8.9x, which means recent weakness sits on top of a very strong long term share price performance. The expanded manufacturing partnership with Cerebras for AI accelerator...

Vericel stock has delivered a 32.0% return over the past year, yet its current valuation checks lean expensive, raising the question of how much of the story is already reflected in the share price. Over the last 1 year, Vericel has returned 32.0%. This puts recent shareholder gains front and center in any discussion of what the stock is worth today. For a company like Vericel, expectations around sustaining growth in its therapies can support the current pricing. However, any setback in...